€ 0.86
Key Takeaways
Risk factor
Very high price volatility
Data is available to registered users only
Data is available to registered users only
Profitability factor
Very favourable analyst view
Data is available to registered users only
Data is available to registered users only
About
Helsinki, Finland-based Nanoform Finland Oyj provides advanced nanotechnology and drug particle engineering solutions for the pharmaceutical sector across Europe and the United States. The company specializes in the production of nanoparticles, utilizing its exclusive "controlled expansion of supercritical solutions" technology, which aids its clients in their development processes. Nanoform was established in 2008.
Company Valuation
Considering past and projected metrics, the stock is moderately 'expensive' compared to its peers.
Data is available to registered users only